EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Distinct Roles for Thymic Stromal Lymphopoietin ( TSLP ) and IL ‐33 in Experimental Eosinophilic Esophagitis

Anish Dsilva, Ariel Wagner, Michal Itan, Natalie Rhone, Shmulik Avlas, Yaara Gordon, Natalie Davidian, Shraddha Sharma, Elizaveta Razravina, Israel Zan-Bar, Jane R Parnes, Kevin S Gorski and 5 more

Allergy · 2025-11 · 80 (11) · 3095-3107

DOI: 10.1111/all.16682 ↗

At a glance

Journal article in Allergy, published online on 2025-07-29. Written by Anish Dsilva and 16 co-authors. Institution: Department of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel. Major MEDLINE topics: Eosinophilic Esophagitis, Thymic Stromal Lymphopoietin, Interleukin-33. Cited 8 times so far (Crossref); 63 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Israel Science Foundation, US-Israel Bi-national Science Foundation, AstraZeneca.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Rationale

Thymic stromal lymphopoietin (TSLP) and IL‐33 are alarmins implicated in eosinophilic esophagitis (EoE) pathogenesis by activating multiple cells, including mast cells (MCs). Whether TSLP or IL‐33 have a role in EoE and whether their activities are distinct requires further investigation.

Methods

Experimental EoE was induced in wild type (WT) Il33 −/− and Crlf2 −/− mice. TSLP or IL‐5 were neutralized using antibodies. Esophageal histopathology was determined by H&E, anti‐Ki67, anti‐CD31, and anti‐MBP staining. Esophageal RNA was subjected to RNA sequencing. Bone marrow‐derived MCs were activated with TSLP and IL‐13 was determined (ELISA).

Results

TSLP and IL‐33 were overexpressed in human and experimental EoE. Human and mouse esophageal MCs displayed the highest level of Crlf2 (TSLPR) compared to other immune cells. Crlf2 −/− mice were nearly completely protected from EoE, and TSLP neutralization resulted in decreased basal cell proliferation, eosinophilia, lamina propria thickening, and vascularization. Induction of experimental EoE in Il33 −/− mice resulted in reduced eosinophilia, but no alterations in tissue remodeling were observed compared to WT mice. RNA sequencing revealed that TSLP regulates the expression of key genes associated with human EoE (e.g., eotaxins, Il19 , Klk5 , Flg , Il36rn , Il1r2 ) and suggests a role for TSLP in regulating IL‐1 signaling, barrier integrity, and epithelial cell differentiation. Experimental EoE was characterized by a MC‐associated gene signature and elevated MCs. Activation of MCs with TSLP resulted in the secretion of IL‐13.

Conclusion

TSLP and IL‐33 have non‐redundant functions in experimental EoE. This study highlights TSLP as an upstream regulator of IL‐13 and a potential therapeutic target for EoE.

Subjects

MeSH terms (MEDLINE)

Eosinophilic EsophagitisThymic Stromal LymphopoietinInterleukin-33MaleAnimalsMiceMice, Inbred C57BLMice, KnockoutDisease Models, AnimalMast CellsEosinophilsSignal TransductionHumansReceptors, Cytokine

Author keywords

IL‐33TSLPallergyeosinophilic esophagitis

Substances

TSLP protein, mouseThymic Stromal LymphopoietinIl33 protein, mouseInterleukin-33TSLP protein, humanIL33 protein, humanReceptors, Cytokine

Authors and institutions

  • Department of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.
  • Early Development, Amgen, Thousand Oaks, California, USA.
  • Clinical Biomarkers and Diagnostics, Amgen, South San Francisco, California, USA.
  • Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Research Center for Digestive Tract and Liver Diseases, Sourasky Medical Center, Tel Aviv, Israel.
  • Center for Fundamental Immunology, Benaroya Research Institute, Seattle, Washington, USA.

ORCID profiles: Ariel Munitz

Funding

  • Israel Science Foundation
  • US-Israel Bi-national Science Foundation
  • AstraZeneca
  • Israel Cancer Research Fund
  • Israel Cancer Association USA
  • Azrieli Foundation Canada-Israel
  • Campaign Urging Research for Eosinophilic Disease
  • NIDDK NIH HHS

Cite

APA

Dsilva, A., Wagner, A., Itan, M., Rhone, N., Avlas, S., Gordon, Y., Davidian, N., Sharma, S., Razravina, E., Zan-Bar, I., Parnes, J. R., Gorski, K. S., Sherrill, J. D., Varol, C., Ziegler, S. F., Rothenberg, M. E., & Munitz, A. (2025). Distinct Roles for Thymic Stromal Lymphopoietin ( TSLP ) and IL ‐33 in Experimental Eosinophilic Esophagitis. Allergy, 80(11), 3095-3107. https://doi.org/10.1111/all.16682

Vancouver

Dsilva A, Wagner A, Itan M, Rhone N, Avlas S, Gordon Y, et al. Distinct Roles for Thymic Stromal Lymphopoietin ( TSLP ) and IL ‐33 in Experimental Eosinophilic Esophagitis. Allergy. 2025;80(11):3095-3107. doi:10.1111/all.16682

BibTeX
@article{Dsilva2025,
  author = {Dsilva, Anish and Wagner, Ariel and Itan, Michal and Rhone, Natalie and Avlas, Shmulik and Gordon, Yaara and Davidian, Natalie and Sharma, Shraddha and Razravina, Elizaveta and Zan-Bar, Israel and Parnes, Jane R and Gorski, Kevin S and Sherrill, Joseph D and Varol, Chen and Ziegler, Steven F and Rothenberg, Marc E and Munitz, Ariel},
  title = {Distinct Roles for Thymic Stromal Lymphopoietin ( TSLP ) and IL ‐33 in Experimental Eosinophilic Esophagitis},
  journal = {Allergy},
  year = {2025},
  volume = {80},
  number = {11},
  pages = {3095--3107},
  doi = {10.1111/all.16682}
}
Start for free →